Zobrazeno 1 - 4
of 4
pro vyhledávání: '"392"'
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Background A randomized trial demonstrated that capecitabine is at least as effective as fluorouracil in the adjuvant treatment of patients with locally advanced rectal cancer. However, not all patients receive all planned cycles of chemotherapy. The
Publikováno v:
BMC Cancer
BMC CANCER(17)
BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)
BMC CANCER(17)
BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)
Background In this study, we aimed to develop an objective staging system to determine the degree of nodal metastasis in breast cancer patients undergoing neoadjuvant systemic treatment (NST). Methods We reviewed the pretreatment computed tomography
Publikováno v:
BMC Cancer
Background Sorafenib is the standard first-line therapy for hepatocellular carcinoma (HCC) and probably ectopic hepatocellular carcinoma (EHCC) as well. No report involves a side effect of delayed high fever of sorafenib. This manuscript describes a
Autor:
Hye-Jeong Lee, Byoung Wook Choi, Young Jin Kim, Hee Yeong Kim, Kyung Young Chung, Yoo Jin Hong, Se Kyu Kim, Joon Chang, Joo-Hang Kim, Ji Eun Nam, Jin Hur, Hye Sun Lee
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 392 (2012)
BMC Cancer
BMC CANCER(12)
BMC Cancer
BMC CANCER(12)
Background Cytological fluid from a needle aspiration biopsy (NAB) is obtained directly from tumor tissue, therefore many biomarker candidates will be present in high concentrations. The aim of this study was to prospectively assess and validate the